In addition, CRP concentrations were significantly lower in CRC patients in stage I (p = 0.024) and stage II (p = 0.048) in comparison to CRC subjects in stage IV, which was calculated using a post hoc wg Dwass–Steele–Critchlow–Fligner test (Table 3). This evidence concerns the gene CRP and colorectal carcinoma.